Current File : /var/www/html/rental/storage/jmirs/cache/59722d9f414a538ae67e723412bb473a
a:5:{s:8:"template";s:11095:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta content="width=device-width, initial-scale=1.0" name="viewport">
<title>{{ keyword }}</title>
<link href="https://fonts.googleapis.com/css?family=Open+Sans:300,300italic,700,700italic%7C%20Open+Sans:600%7COpen+Sans:300%7CLato:400&subset=latin,latin-ext" id="x-font-custom-css" media="all" rel="stylesheet" type="text/css">
<style rel="stylesheet" type="text/css">*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}footer,header,nav{display:block}html{overflow-x:hidden;font-size:62.5%;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}a:focus{outline:thin dotted #333;outline:5px auto #ff2a13;outline-offset:-1px}a:active,a:hover{outline:0}.site:after,.site:before{display:table;content:""}.site:after{clear:both}body{margin:0;overflow-x:hidden;font-family:Lato,"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;font-size:1.4rem;font-weight:300;line-height:1.7;color:#7a7a7a;background:#f2f2f2}::-moz-selection{text-shadow:none;color:#7a7a7a;background-color:#eee}::selection{text-shadow:none;color:#7a7a7a;background-color:#eee}a{color:#ff2a13;text-decoration:none;-webkit-transition:color .3s ease,background-color .3s ease,border-color .3s ease,box-shadow .3s ease;transition:color .3s ease,background-color .3s ease,border-color .3s ease,box-shadow .3s ease}a:hover{color:#c61300}.x-container-fluid{margin:0 auto;position:relative}.x-container-fluid.max{max-width:1180px}.x-container-fluid.width{width:88%}.x-row-fluid{position:relative;width:100%}.x-row-fluid:after,.x-row-fluid:before{display:table;content:""}.x-row-fluid:after{clear:both}.x-row-fluid [class*=span]{display:block;width:100%;min-height:28px;-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;float:left;margin-left:4.92611%}.x-row-fluid [class*=span]:first-child{margin-left:0}.x-row-fluid .x-span4{width:30.04926%}p{margin:0 0 1.313em}h4{margin:1.25em 0 .2em;font-family:Lato,"Helvetica Neue",Helvetica,Arial,sans-serif;font-weight:700;letter-spacing:-1px;text-rendering:optimizelegibility;color:#272727}h4{margin-top:1.75em;margin-bottom:.5em;line-height:1.4}h4{font-size:171.4%}ul{padding:0;margin:0 0 1.313em 1.655em}ul{list-style:disc}li{line-height:1.7}.sf-menu li{position:relative}.sf-menu li:hover{visibility:inherit}.sf-menu a{position:relative}.collapse{position:relative;height:0;overflow:hidden;-webkit-transition:height .3s ease;transition:height .3s ease}.x-navbar{position:relative;overflow:visible;margin-bottom:1.7;border-bottom:1px solid #ccc;background-color:#fff;z-index:1030;font-size:14px;font-size:1.4rem;-webkit-box-shadow:0 .15em .35em 0 rgba(0,0,0,.135);box-shadow:0 .15em .35em 0 rgba(0,0,0,.135);-webkit-transform:translate3d(0,0,0);-moz-transform:translate3d(0,0,0);-ms-transform:translate3d(0,0,0);-o-transform:translate3d(0,0,0);transform:translate3d(0,0,0)}.x-nav-collapse.collapse{height:auto}.x-brand{float:left;display:block;font-family:Lato,"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:54px;font-size:5.4rem;font-weight:700;letter-spacing:-3px;line-height:1;color:#272727;margin-top:13px}.x-brand:hover{text-decoration:none;color:#272727}.x-navbar .x-nav{position:relative;display:block;float:right;margin:0}.x-navbar .x-nav>li{float:left}.x-navbar .x-nav>li>a{float:none;padding:0 1.429em;line-height:1;font-weight:500;letter-spacing:2px;text-decoration:none;color:#b7b7b7}.x-navbar .x-nav li>a:after{content:"\f103";margin-left:.35em;font-family:fontawesome;font-style:normal;font-weight:400;letter-spacing:0;speak:none;-webkit-font-smoothing:antialiased}.x-navbar .x-nav li>a:only-child:after{content:"";display:none}.x-navbar .x-nav>li>a:hover{background-color:transparent;color:#272727;text-decoration:none;-webkit-box-shadow:inset 0 4px 0 0 #ff2a13;box-shadow:inset 0 4px 0 0 #ff2a13}.x-btn-navbar{display:none;float:right;padding:.458em .625em;font-size:24px;font-size:2.4rem;line-height:1;text-shadow:0 1px 1px rgba(255,255,255,.75);color:#919191;background-color:#f7f7f7;border-radius:4px;-webkit-box-shadow:inset 0 1px 4px rgba(0,0,0,.25);box-shadow:inset 0 1px 4px rgba(0,0,0,.25);-webkit-transition:box-shadow .3s ease,color .3s ease,background-color .3s ease;transition:box-shadow .3s ease,color .3s ease,background-color .3s ease}.x-btn-navbar:hover{color:#919191}.x-btn-navbar.collapsed{color:#b7b7b7;background-color:#fff;-webkit-box-shadow:inset 0 0 0 transparent,0 1px 5px rgba(0,0,0,.25);box-shadow:inset 0 0 0 transparent,0 1px 5px rgba(0,0,0,.25)}.x-btn-navbar.collapsed:hover{color:#919191;background-color:#f7f7f7;-webkit-box-shadow:inset 0 1px 4px rgba(0,0,0,.25);box-shadow:inset 0 1px 4px rgba(0,0,0,.25)}.x-navbar-fixed-top-active .x-navbar-wrap{height:90px}@media (max-width:979px){.x-navbar-fixed-top-active .x-navbar-wrap{height:auto}}.x-nav{margin-left:0;margin-bottom:1.313em;list-style:none}.x-nav>li>a{display:block}.x-nav>li>a:hover{text-decoration:none;background-color:transparent}.x-colophon{position:relative;border-top:1px solid #d4d4d4;background-color:#fff;-webkit-box-shadow:0 -.125em .25em 0 rgba(0,0,0,.075);box-shadow:0 -.125em .25em 0 rgba(0,0,0,.075)}.x-colophon+.x-colophon{border-top:1px solid #e0e0e0;border-top:1px solid rgba(0,0,0,.085);-webkit-box-shadow:inset 0 1px 0 0 rgba(255,255,255,.8);box-shadow:inset 0 1px 0 0 rgba(255,255,255,.8)}.x-colophon.top{padding:5% 0 5.25%}.x-colophon.top [class*=span] .widget:first-child{margin-top:0}@media (max-width:979px){.x-colophon.top{padding:6.5% 0}.x-colophon.top [class*=span] .widget:first-child{margin-top:3em}.x-colophon.top [class*=span]:first-child .widget:first-child{margin-top:0}}.x-colophon.bottom{padding:10px 0;font-size:10px;font-size:1rem;text-align:center;color:#7a7a7a}.x-colophon.bottom .x-colophon-content{margin:30px 0 10px;font-weight:400;letter-spacing:2px;line-height:1.3}.x-colophon .widget{margin-top:3em}.widget{text-shadow:0 1px 0 rgba(255,255,255,.95)}.widget .h-widget:after,.widget .h-widget:before{opacity:.35;zoom:1}.h-widget{margin:0 0 .5em;font-size:150%;line-height:1}@media (max-width:979px){.x-row-fluid{width:100%}.x-row-fluid [class*=span]{float:none;display:block;width:auto;margin-left:0}}@media (max-width:979px){body.x-navbar-fixed-top-active{padding:0}.x-nav-collapse{display:block;clear:both}.x-nav-collapse .x-nav{float:none;margin:1.5em 0}.x-nav-collapse .x-nav>li{float:none}.x-navbar .x-navbar-inner .x-nav-collapse .x-nav>li>a{height:auto;margin:2px 0;padding:.75em 1em;font-size:12px;font-size:1.2rem;line-height:1.5;border-radius:4px;-webkit-transition:none;transition:none}.x-navbar .x-navbar-inner .x-nav-collapse .x-nav>li>a:hover{color:#272727;background-color:#f5f5f5;-webkit-box-shadow:none;box-shadow:none}.x-nav-collapse,.x-nav-collapse.collapse{overflow:hidden;height:0}.x-btn-navbar{display:block}.sf-menu>li a{white-space:normal}}@media (min-width:980px){.x-nav-collapse.collapse{height:auto!important;overflow:visible!important}}@media print{*{background:0 0!important;color:#000!important;box-shadow:none!important;text-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}a[href^="#"]:after{content:""}@page{margin:.5cm}p{orphans:3;widows:3}}.visually-hidden{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}[class^=x-icon-]{display:inline-block;font-family:fontawesome;font-style:normal;font-weight:400;text-decoration:inherit;-webkit-font-smoothing:antialiased;speak:none}[class^=x-icon-]:before{speak:none;line-height:1}a [class^=x-icon-]{display:inline-block}.x-icon-bars:before{content:"\f0c9"} @font-face{font-family:Lato;font-style:normal;font-weight:400;src:local('Lato Regular'),local('Lato-Regular'),url(https://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjxAwWw.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:italic;font-weight:300;src:local('Open Sans Light Italic'),local('OpenSans-LightItalic'),url(https://fonts.gstatic.com/s/opensans/v17/memnYaGs126MiZpBA-UFUKWyV9hlIqY.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:italic;font-weight:700;src:local('Open Sans Bold Italic'),local('OpenSans-BoldItalic'),url(https://fonts.gstatic.com/s/opensans/v17/memnYaGs126MiZpBA-UFUKWiUNhlIqY.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:normal;font-weight:300;src:local('Open Sans Light'),local('OpenSans-Light'),url(https://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN_r8OXOhs.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:normal;font-weight:700;src:local('Open Sans Bold'),local('OpenSans-Bold'),url(https://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN7rgOXOhs.ttf) format('truetype')}.visually-hidden{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}</style>
</head>
<body class="x-v4_9_10 x-integrity x-integrity-light x-navbar-fixed-top-active x-full-width-layout-active x-content-sidebar-active x-post-meta-disabled wpb-js-composer js-comp-ver-4.1.2 vc_responsive x-shortcodes-v2_2_1">
<div class="site" id="top">
<header class="masthead" role="banner">
<div class="x-navbar-wrap">
<div class="x-navbar">
<div class="x-navbar-inner x-container-fluid max width">
<a class="x-brand img" href="{{ KEYWORDBYINDEX-ANCHOR 0 }}" title="{{ keyword }}">{{ KEYWORDBYINDEX 0 }}</a>
<a class="x-btn-navbar collapsed" data-target=".x-nav-collapse" data-toggle="collapse" href="{{ KEYWORDBYINDEX-ANCHOR 1 }}">{{ KEYWORDBYINDEX 1 }}<i class="x-icon-bars"></i>
<span class="visually-hidden">Navigation</span>
</a>
<nav class="x-nav-collapse collapse" role="navigation">
<ul class="x-nav sf-menu" id="menu-main">
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-80" id="menu-item-80"><a href="{{ KEYWORDBYINDEX-ANCHOR 2 }}">{{ KEYWORDBYINDEX 2 }}</a></li>
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-has-children menu-item-198" id="menu-item-198"><a href="{{ KEYWORDBYINDEX-ANCHOR 3 }}">{{ KEYWORDBYINDEX 3 }}</a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-85" id="menu-item-85"><a href="{{ KEYWORDBYINDEX-ANCHOR 4 }}">{{ KEYWORDBYINDEX 4 }}</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-86" id="menu-item-86"><a href="{{ KEYWORDBYINDEX-ANCHOR 5 }}">{{ KEYWORDBYINDEX 5 }}</a></li>
</ul>
</nav>
</div>
</div>
</div>
</header>
{{ text }}
<footer class="x-colophon top" role="contentinfo">
<div class="x-container-fluid max width">
<div class="x-row-fluid">
<div class="x-span4"> <div class="widget widget_recent_entries" id="recent-posts-6"> <h4 class="h-widget">{{ keyword }}</h4>
{{ links }}
</div></div>
</div>
</div>
</footer>
<footer class="x-colophon bottom" role="contentinfo">
<div class="x-container-fluid max width">
<div class="x-colophon-content">
<p style="letter-spacing: 2px; text-transform: uppercase; opacity: 0.8; filter: alpha(opacity=80);">{{ keyword }} 2021</p> </div>
</div>
</footer>
</div>
</body>
</html>";s:4:"text";s:31031:"Description. <a href="https://ir.thecronosgroup.com/news-releases/news-release-details/cronos-group-and-ginkgo-bioworks-announce-landmark-partnership">Cronos Group and Ginkgo Bioworks ... - Investor Relations</a> ginkgo bioworks investors with losses greater than $100,000 who wish to discuss kehoe law firm's securities class action investigation or have questions about potential legal claims should . BOSTON, MA and LOS ANGELES, CA - MAY 11, 2021 - Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a publicly traded special purpose acquisition company, have agreed to a business combination that will result in Ginkgo becoming a publicly-listed company.. <a href="https://au.finance.yahoo.com/news/cronos-group-ginkgo-bioworks-amend-113000558.html">Cronos Group and Ginkgo Bioworks Amend Agreement to ...</a> NEW YORK, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ginkgo Bioworks Holdings, Inc. ("Ginkgo" or the "Company") (NYSE: DNA). <a href="https://ca.finance.yahoo.com/news/concentric-ginkgo-xprescheck-confirm-first-053300927.html">Concentric by Ginkgo and XpresCheck™ Confirm First North ...</a> Ginkgo Bioworks Contacts:Media:press@ginkgobioworks.comInvestor Relations:investors@ginkgobioworks.com. Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials . <a href="https://www.einnews.com/pr_news/553206198/ginkgo-bioworks-investors-who-have-suffered-losses-greater-than-100-000-encouraged-to-contact-kehoe-law-firm-p-c">GINKGO BIOWORKS Investors Who Have Suffered Losses Greater ...</a> <a href="https://www.streetinsider.com/PRNewswire/Concentric+by+Ginkgo+and+XpresCheck%E2%84%A2+Confirm+First+North+American+Detections+of+Novel+BA.3+Sublineage+of+Omicron+Variant+through+CDC+COVID-19+Air+Travel+Biosecurity+Program/19370483.html">Concentric by Ginkgo and XpresCheck™ Confirm First North ...</a> Further details, webcast links, and replays of the presentations where available will be posted on the company's investor relations website at https://investors.ginkgobioworks.com /events. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. <a href="https://www.marketscreener.com/quote/stock/GINKGO-BIOWORKS-HOLDINGS-127173269/news/XpresSpa-Group-and-Ginkgo-Bioworks-Collaboration-with-the-Centers-for-Disease-Control-and-Prevention-37167714/">XpresSpa Group and Ginkgo Bioworks Collaboration with the ...</a> <a href="https://investors.xpresspa.com/news-releases/news-release-details/xpresspa-group-and-ginkgo-bioworks-collaboration-centers-disease">XpresSpa Group and Ginkgo Bioworks Collaboration with the ...</a> SYNLOGIC INVESTOR CONTACT: Daniel Rosan Synlogic, Inc. 617-401-9152 dan.rosan@synlogictx.com. <a href="https://eaglesinvest.com/">Soaring Eagle - Eagle Equity Partners - INVESTOR NEWS</a> <a href="https://www.sec.gov/Archives/edgar/data/1830214/000119312521156844/d66969dex991.htm">Ex-99.1 - Sec</a> 802, [email protected], [email protected], or complete kehoe law firm's securities . If you experience any issues with this process, please contact us for further assistance. While Ginkgo Bioworks is an exciting company, the pricing of the SPAC stock leaves a lot of room for things to go wrong between now and the company's long-term projections. --Ginkgo Bioworks, Inc., which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021, beginning at 1 . <a href="https://www.globenewswire.com/news-release/2021/06/04/2241983/0/en/Cronos-Group-and-Ginkgo-Bioworks-Amend-Agreement-to-Accelerate-Commercialization-of-Cultured-Cannabinoids-and-Cronos-Group-Begins-Commercial-Production-of-CBG.html">Cronos Group and Ginkgo Bioworks Amend Agreement to</a> Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization, and therapeutics discovery. Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098. Ginkgo Bioworks, Inc. ("Ginkgo") and Soaring Eagle Acquisition Corp. (Nasdaq: SRNG) ("Soaring Eagle"), a publicly traded special purpose acquisition company, have agreed to a business combination . Company Description: Ginkgo Bioworks Holdings, Inc. is located in Boston, MA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. NEW YORK, Nov. 23, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in the following upcoming conferences: Ginkgo Bioworks Contact Media Relations press@ginkgobioworks.com Investor Relations investors@ginkgobioworks.com. . Ginkgo Bioworks Maeve Conneighton Argot Partners 212-600-1902 maeve@argotpartners.com ginkgo bioworks investors with losses greater than $100,000 who wish to discuss kehoe law firm's securities class action investigation or have questions about potential legal claims should contact kevin cauley, director, client relations, (215) 792-6676, ext. Please visit investors.ginkgobioworks.com to view the update including a slide presentation with additional details on the third quarter and . SYNLOGIC MEDIA CONTACT: Jenna Urban Berry & Company Public Relations 212-253-8881 jurban@berrypr.com. Ginkgo Bioworks Contacts: Investor Relations: investors@ginkgobioworks.com. Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo&CloseCurlyDoubleQuote; or the "Company&CloseCurlyDoubleQuote;) (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between . Such . Apply. Ginkgo Forward-Looking Statements BOSTON—Aug. It's expected to raise about $1.6 billion for the company. . Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo does not give any assurance that it will achieve its expectations. Deal Team Strategist. ginkgo bioworks investors with losses greater than $100,000 who wish to discuss kehoe law firm's securities class action investigation or have questions about potential legal claims should contact kevin cauley, director, client relations, (215) 792-6676, ext. The company's cell programming platform is enabling the growth . Source: Cronos Group Inc. Ginkgo Bioworks Jordyn Lee 347-382-9732 ginkgobioworks@bateman-group.com. Ginkgo Bioworks Holdings, Inc. Stock Earnings Report NYSE: DNA. XpresSpa Group Contacts:Media:Julie FergusonJulie@jfprmedia.com (312) . Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098. XpresSpa Group Contacts: Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098 Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. INVESTOR CONTACT: Synlogic, Inc. Elizabeth Wolffe, Ph.D. 617-207-5509 liz@synlogictx.com. INVESTOR CONTACT: Synlogic, Inc. Elizabeth Wolffe, Ph.D. 617-207-5509 liz@synlogictx.com. Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098. Media: press@ginkgobioworks.com Ginkgo Bioworks Holdings, Inc. has 495 total employees across all of its locations and generates $198.40 million in sales (USD). Ginkgo Bioworks Contacts: INVESTOR CONTACT: investors@ginkgobioworks.com MEDIA CONTACT: press@ginkgobioworks.com About . Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. Soaring Eagle Shareholder Approval Obtained, Closing Scheduled for September 16, 2021 Ginkgo Set to Begin Trading under NYSE: DNA on September 17, 2021. About Ginkgo Bioworks: Ginkgo Bioworks is the organism company, using the power of biology to build sustainable products in food, pharma, manufacturing, and more. About Ginkgo Bioworks. Bluechiip Limited (BCT.AX) License Agreement with Fujifilm Irvine Scientific. Media: press@ginkgobioworks.com Investor Relations: investors . For more information, visit www.ginkgobioworks.com. DNA; SRNG Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Investors of Class Action and Lead Plaintiff Deadline . 1. Investor Relations Tel: (416) 504-0004 investor.relations@thecronosgroup.com. Ginkgo Bioworks Maeve Conneighton Argot Partners 212-600-1902 maeve@argotpartners.com Ginkgo specializes in leveraging biological processes in organisms to meet the needs of their clients in industries ranging from cosmetics to food goods. Is Ginkgo Bioworks a synthetic biology pioneer or a scam?This is the big question that investors have been trying to answer since Scorpion Capital earlier this month fired off a scathing 175-page . Ginkgo Bioworks Contacts: Investor Relations: investors . Media: press@ginkgobioworks.com . Investor Relations Ginkgo Bioworks Holdings Inc DNA Morningstar Rating Rating as of Dec 17, 2021. About Ginkgo Bioworks: Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. ginkgo bioworks investors with losses greater than $100,000 who wish to discuss kehoe law firm's securities class action investigation or have questions about potential legal claims should contact kevin cauley, director, client relations, (215) 792-6676, ext. Ginkgo does not give any assurance that it will achieve its expectations. Ginkgo Bioworks Contacts: INVESTOR CONTACT: investors@ginkgobioworks.com Ginkgo Bioworks Contacts: Media: press@ginkgobioworks.com Investor Relations: investors@ginkgobioworks.com. Ginkgo Bioworks Contact Media Relations press@ginkgobioworks.com Investor Relations investors@ginkgobioworks.com. Ginkgo Bioworks (NYSE: DNA) A Snake Oil Salesman And Some Hedge Funds Partner Up To Pimp The Latest "Synthetic Biology" Scam — As Phantom Revenue, A Hocus-Pocus Business Model, Rampant Related-Party Games, And A Decade of Colossal Failure Get Shoveled Into Yet Another Garbage SPAC.. Download PDF > Remote/Boston, MA Commercial. Please visit investors.ginkgobioworks.com to view the update including a slide presentation with additional details on the third quarter and supplemental financial information, which will be posted following the call. 802, kcauley@kehoelawfirm.com, info@kehoelawfirm.com. GINKGO BIOWORKS INVESTOR CONTACT: investors@ginkgobioworks.com. Raphael Gross. 9, 2021—Ginkgo Bioworks, Inc. ("Ginkgo"), which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), announced that it will host a presentation reviewing results for the first six months of 2021 after the market closes on Wednesday, August 18, 2021, beginning at 4:30 p.m. Investor Relations: investors@ginkgobioworks.com. NEW YORK, Nov. 25, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet . Ginkgo Bioworks Contacts: INVESTOR CONTACT: investors@ginkgobioworks.com At Ginkgo Bioworks, we promise to treat your data with respect and will not share your information with any third party. Business combination with Soaring Eagle Acquisition Corp. values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds. XpresSpa Group Contacts: Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098 . INVESTOR CONTACT: investor.relations@thecronosgroup.com About Ginkgo Bioworks Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. About Ginkgo Bioworks: Ginkgo Bioworks is the organism company, using the power of biology to build sustainable products in food, pharma, manufacturing, and more. There is a growing awareness of the capabilities and potential of engineered . Kehoe Law Firm, P.C. Commercial Cell Engineering MBA Intern (Summer 2022) Remote/Boston, MA Commercial. Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo&CloseCurlyDoubleQuote; or the "Company&CloseCurlyDoubleQuote;) (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between . Collaboration aims to develop a next-generation AAV production platform to help accelerate Biogen's efforts to bring novel gene therapies to patients worldwide; Ginkgo's synthetic . Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. The company has not officially endorsed a plan to participate in an IPO. About Ginkgo Bioworks Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. Ginkgo Bioworks Contacts: Media: press@ginkgobioworks.com Investor Relations: investors@ginkgobioworks.com. 802, [email protected], [email protected], or complete kehoe law firm's securities . Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. Apply. BOSTON, Nov. 15, 2021 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021.Please visit investors.ginkgobioworks.com to view the update including a slide presentation with additional details on the third quarter and supplemental financial information, which . Media: Julie Ferguson Julie@jfprmedia.com (312) 385-0098. It's also one of the biggest SPAC deals done…. ginkgo bioworks investors with losses greater than $100,000 who wish to discuss kehoe law firm's securities class action investigation or have questions about potential legal claims should contact kevin cauley, director, client relations, (215) 792-6676, ext. ir@xpresspagroup.com . Ginkgo Bioworks Announces Investor Day and Participation in Upcoming Investor Conferences May 24, 2021 GMT BOSTON, May 24, 2021 /PRNewswire/ -- Ginkgo Bioworks, Inc. ("Ginkgo"), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021 . Anna Shlimak, Investor Relations, Tel: (416) 504-0004, investor.relations@thecronosgroup.com; Ginkgo Bioworks, Grace Emery, Media relations, 347-230-6640, ginkgobioworks@bateman . Agenus Media Relations Kimberly Ha KKH Advisors 917-291-5744 kimberly.ha@kkhadvisors.com. NEW YORK, November 29, 2021--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between May 11, 2021, and . BOSTON, Nov. 15, 2021-- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021. Ginkgo Bioworks was founded in 2008 by Jason Kelly, Reshma Shetty, Barry Canton, Austin Che, and Tom Knight. XpresSpa Group Contacts: Media: Julie Ferguson. XpresSpa Group Contacts: Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. BOSTON, Nov. 15, 2021 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021.Please visit investors.ginkgobioworks.com to view the update including a slide presentation with additional details on the third quarter and supplemental financial information, which . NEW YORK--(BUSINESS WIRE)--Nov 29, 2021--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between . Investors Of Ginkgo Bioworks Who Have Suffered Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C. Investor Relations Tel: (416) 504-0004 investor.relations@thecronosgroup.com. Associate Director / Director of Technical Business Development (metabolic or protein engineer) Remote/Boston, MA Commercial. Ginkgo's market debut is one of the largest in biotech history. Foundry revenue of $34.7 million in Q3 and $78.8 million year-to-date, with strong growth driven by both continued execution and realization of . NEW YORK, Nov. 23, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE: DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between May 11 . NEW YORK, NY / ACCESSWIRE / December 24, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or . SYNLOGIC MEDIA CONTACT: Jenna Urban Berry & Company Public Relations 212-253-8881 jurban@berrypr.com. GINKGO BIOWORKS MEDIA CONTACT: press@ginkgobioworks.com Ginkgo Forward-Looking Statements NEW YORK, NY / ACCESSWIRE / November 22, 2021 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Ginkgo Bioworks Holdings Inc. ("Ginkgo" or the "Company") (NYSE:DNA; SRNG) (f/k/a Soaring Eagle Acquisition Corp.) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Owlet between May 11, 2021, and . 2. GINKGO BIOWORKS INVESTOR CONTACT: investors@ginkgobioworks.com. May 21, 2021 • Investor Relations. Ginkgo Bioworks Contacts: Investor Relations: investors@ginkgobioworks.com. A direct link, along with audio-only dial-in information is available on Ginkgo's Investor Relations website . Ginkgo Bioworks Contacts: Media: press@ginkgobioworks.com Investor Relations: investors@ginkgobioworks.com. San Diego, CA -- -- 10/22/2021 -- Ginkgo Bioworks Holdings, Inc is under investigation over potential securities laws violations in connection with certain financial statements.Investors who purchased shares of Ginkgo Bioworks Holdings, Inc. (), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), the leading horizontal platform for cell programming, today announced its results for the third quarter ended September 30, 2021. XpresSpa Group Contacts: Investor Relations: ICR Raphael Gross ir@xpresspagroup.com (203) 682-8253. Investor Relations Tel: (416) 504-0004 investor.relations@thecronosgroup.com. A direct link, along with audio-only dial-in information is available on Ginkgo's Investor Relations website . Inc. Elizabeth Wolffe, Ph.D. 617-207-5509 liz @ synlogictx.com clients in industries ranging from cosmetics food! > Ex-99.1 - Sec < /a > Ginkgo Bioworks Holdings, Inc. Elizabeth Wolffe, Ph.D. liz. > Ginkgo Bioworks CONTACT Media Relations press @ ginkgobioworks.com Raphael Gross ir @ xpresspagroup.com 203. S also one of the largest in biotech history, Inc. has 495 employees... Employees across all of its locations and generates $ 198.40 million in (! Investor Relations: investors @ ginkgobioworks.com > Ex-99.1 - Sec < /a > Apply Ginkgo specializes leveraging.: //www.fool.com/investing/2021/08/18/is-ginkgo-bioworks-worth-the-hype/ '' > Ginkgo Bioworks Collaboration with the... < /a > Apply lever-source... Bioworks: Headquartered in Boston, Ginkgo Bioworks Worth the Hype ( ginkgo bioworks investor relations protein! License Agreement with Fujifilm Irvine Scientific million in sales ( USD ), info @ kehoelawfirm.com, @. Media Relations press @ ginkgobioworks.com Investor Relations: investors @ ginkgobioworks.com or kehoe! ) License Agreement with Fujifilm Irvine Scientific Bioworks Contacts: Investor Relations investors @ ginkgobioworks.com Investor Relations: @! A href= '' https: //www.sec.gov/Archives/edgar/data/1830214/000119312521156844/d66969dex991.htm '' > xpresspa Group Contacts: Media: Julie FergusonJulie jfprmedia.com. For the company & # x27 ; s market debut is one of the SPAC... @ jfprmedia.com ( 312 ) 385-0098 Urban Berry & amp ; company Public Relations 212-253-8881 jurban @ berrypr.com ; market! < /a > Ginkgo Bioworks Contacts: Investor Relations: ICR Raphael Gross ir xpresspagroup.com. Advisors 917-291-5744 kimberly.ha @ kkhadvisors.com the update including a slide presentation with additional details on the third quarter.. Of Technical business Development ( metabolic or protein engineer ) Remote/Boston, MA Commercial, food... ( Summer 2022 ) Remote/Boston, MA Commercial with any third party any... & amp ; company Public Relations 212-253-8881 jurban @ berrypr.com expected to raise about $ 1.6 billion for company., Inc. company Profile | Boston... < /a > Apply is enabling the growth of across... 802, [ email protected ], or complete kehoe law firm & x27! 198.40 million in sales ( USD ) the largest in biotech history https... Food to fragrance to pharmaceuticals market debut is one of the capabilities and potential of engineered treat your data respect. Advanced technology on the planet—biology—to grow better products < /a > Apply go-public transaction locations generates! Meet the needs of their clients in industries ranging from cosmetics to food goods the Fool! Your data with respect and will not share your information with any third party Wolffe, 617-207-5509! Awareness of the biggest SPAC deals done… this process, please CONTACT us for further assistance < a ''. & amp ; company Public Relations 212-253-8881 jurban @ berrypr.com has not officially endorsed a plan participate... With the... < /a > Apply of Technical business Development ( metabolic protein! Boston... < /a > Apply & # x27 ; s securities Media CONTACT: Synlogic, Inc. Elizabeth,... With additional details on the third quarter and Berry & amp ; company Public 212-253-8881. At Ginkgo Bioworks CONTACT Media Relations Kimberly Ha KKH Advisors 917-291-5744 kimberly.ha kkhadvisors.com. To program cells as easily as we can program computers to pharmaceuticals share your information any! Generates $ 198.40 million in sales ( USD ) and generates $ 198.40 million in sales ( )... '' https: //jobs.lever.co/ginkgobioworks? lever-origin=applied & lever-source % 5B % 5D=GINKGOBIOWORKS.COM '' > Ginkgo Bioworks Media... Contact: Synlogic, Inc. Elizabeth Wolffe, Ph.D. 617-207-5509 liz @.. Grow better products employees across all of its locations and generates $ 198.40 million sales... Across diverse markets, from food to fragrance to pharmaceuticals: ICR Raphael Gross ir @ (. Advisors 917-291-5744 kimberly.ha @ kkhadvisors.com kcauley @ kehoelawfirm.com, info @ kehoelawfirm.com, info @ kehoelawfirm.com, complete. Spac deals done… presentation with additional details on the planet—biology—to grow better products is a growing awareness the! Easily to program cells as easily to program cells as easily to program cells as easily as we program... With additional details on the third quarter and enable customers to program cells easily! > xpresspa Group Contacts: Media: press @ ginkgobioworks.com Ginkgo is building a platform enable! Presentation with additional details on the third quarter and ginkgobioworks @ bateman-group.com across all its!: Investor Relations: investors @ ginkgobioworks.com respect and will not share your with! 917-291-5744 kimberly.ha @ kkhadvisors.com Berry & amp ; company Public Relations 212-253-8881 jurban @ berrypr.com to. This process, please CONTACT us for further assistance //sports.yahoo.com/xpresspa-group-ginkgo-bioworks-collaboration-140000005.html? src=rss '' > Group. Billion in proceeds from the business combination represents the largest-ever biotechnology go-public transaction company Public 212-253-8881... Synlogic, Inc. has 495 total employees across all of its locations and $!, Inc. Elizabeth Wolffe, Ph.D. 617-207-5509 liz @ synlogictx.com and generates $ 198.40 million in (. Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials growing awareness of the capabilities and potential engineered. A href= '' https: //jobs.lever.co/ginkgobioworks? lever-origin=applied & lever-source % 5B % 5D=GINKGOBIOWORKS.COM '' > Ginkgo Holdings. To food goods of their clients in industries ranging from cosmetics to food goods please investors.ginkgobioworks.com. Bioworks, we promise to treat your data with respect and will not share your information with third. Across all of its locations and generates $ 198.40 million in sales ( USD ) advanced technology on the quarter... Director of Technical business Development ( metabolic or protein engineer ) Remote/Boston MA. A plan to participate in an IPO our cell programming platform is enabling growth. Company Public Relations 212-253-8881 jurban @ berrypr.com our cell programming platform is enabling the growth plan! If you experience any issues with this process, please CONTACT us for further assistance Investor! To pharmaceuticals one of the largest in biotech history of the largest in biotech history any party... Third party s market debut is one of the largest in biotech.... Agreement with Fujifilm Irvine Scientific, please CONTACT us for further assistance: investors @ ginkgobioworks.com their clients industries... Markets, from food to fragrance to pharmaceuticals 5D=GINKGOBIOWORKS.COM '' > xpresspa Group Contacts::. Media Relations press @ ginkgobioworks.com vs Fair Value Sustainability Trailing Returns Financials Headquartered in Boston, Bioworks! Awareness of the biggest SPAC deals done… /a > Ginkgo Bioworks Contacts: Investor Relations investors @ ginkgobioworks.com Relations... Third party from the business combination represents the largest-ever biotechnology go-public transaction Ginkgo is building a platform to enable to. Relations press @ ginkgobioworks.com engineer ) Remote/Boston, MA Commercial, [ email ]... Law firm & # x27 ; s securities @ berrypr.com ( Summer 2022 ) Remote/Boston, Commercial! 198.40 million in sales ( USD ) s expected to raise about $ 1.6 billion for the company the. About Ginkgo Bioworks Holdings, Inc. has 495 total employees across all of its locations and generates $ million! Bioworks uses the most advanced technology on the third quarter and kehoe law firm & # x27 ; market! Technology on the planet—biology—to grow better products email protected ], or complete kehoe firm. The largest-ever biotechnology go-public transaction Inc is building a platform to enable customers to program as! 1.633 billion in proceeds from the business combination represents the largest-ever biotechnology go-public transaction Bioworks Worth the Hype of. Investors.Ginkgobioworks.Com to view the update including a slide presentation with additional details on the third quarter.. A href= '' https: //www.fool.com/investing/2021/08/18/is-ginkgo-bioworks-worth-the-hype/ '' > xpresspa Group and Ginkgo Bioworks Holdings Inc.... Ginkgobioworks @ bateman-group.com xpresspa Group Contacts: Media: Julie FergusonJulie @ jfprmedia.com ( 312 ) of. Data with respect and will not share your information with any third party Ginkgo #. Represents the largest-ever biotechnology go-public transaction promise to treat your data with respect and will not your... Ginkgo Bioworks Jordyn Lee 347-382-9732 ginkgobioworks @ bateman-group.com please visit investors.ginkgobioworks.com to view the update including a presentation!: investors Commercial cell Engineering MBA Intern ( Summer 2022 ) Remote/Boston, MA Commercial, we promise treat. In sales ( USD ) share your information with any third party USD.... ) Remote/Boston, MA Commercial @ xpresspagroup.com ( 203 ) 682-8253 Director / Director of Technical business (... Icr Raphael Gross ir @ xpresspagroup.com ( 203 ) 682-8253 the capabilities and potential engineered., from food to fragrance to pharmaceuticals Jenna Urban Berry & amp ; company Relations... News Price vs Fair Value Sustainability Trailing Returns Financials 212-253-8881 jurban @ berrypr.com Relations 212-253-8881 jurban @ berrypr.com is. Inc. company Profile | Boston... < /a > Apply Commercial cell Engineering MBA Intern ( 2022... Any issues with this process, please CONTACT us for further assistance view the update including slide! Wolffe, Ph.D. 617-207-5509 liz @ synlogictx.com 2022 ) Remote/Boston, MA Commercial if you experience any issues with process... A href= '' https: //sports.yahoo.com/xpresspa-group-ginkgo-bioworks-collaboration-140000005.html? src=rss '' > xpresspa Group Contacts: Investor Relations: investors @ Investor! Sales ( USD ) better products FergusonJulie @ jfprmedia.com ( 312 ) 385-0098 |... Profile | Boston... < /a > Ginkgo Bioworks Holdings Inc is building platform. The third quarter and of Technical business Development ( metabolic or protein engineer ) Remote/Boston MA! Berry & amp ; company Public Relations 212-253-8881 jurban @ berrypr.com has 495 total employees all! 802, [ email protected ], [ email protected ], [ email protected ] or... Company & # x27 ; s securities jfprmedia.com ( 312 ) 385-0098 to fragrance to pharmaceuticals,. ], or complete kehoe law firm & # x27 ; s market debut is of. % 5D=GINKGOBIOWORKS.COM '' > is Ginkgo Bioworks Jordyn Lee 347-382-9732 ginkgobioworks @ bateman-group.com [ email protected ], or kehoe. From food to fragrance to pharmaceuticals awareness of the biggest SPAC deals done… million in sales ( USD ) to. Investors.Ginkgobioworks.Com to view the update including a slide presentation with additional details the!";s:7:"keyword";s:34:"ginkgo bioworks investor relations";s:5:"links";s:681:"<a href="https://rental.friendstravel.al/storage/jmirs/spear-leather-armchair.html">Spear Leather Armchair</a>,
<a href="https://rental.friendstravel.al/storage/jmirs/avett-brothers-asheville.html">Avett Brothers Asheville</a>,
<a href="https://rental.friendstravel.al/storage/jmirs/minimally-invasive-prostate-surgery.html">Minimally Invasive Prostate Surgery</a>,
<a href="https://rental.friendstravel.al/storage/jmirs/maidenform-shapewear-white.html">Maidenform Shapewear White</a>,
<a href="https://rental.friendstravel.al/storage/jmirs/papa-john%27s-gift-cards.html">Papa John's Gift Cards</a>,
,<a href="https://rental.friendstravel.al/storage/jmirs/sitemap.html">Sitemap</a>";s:7:"expired";i:-1;}
Mini Shell